Daminelli, Elaine N; Martinelli, Ana E. M; Bulgarelli, Adriana; Freitas, Fatima R; Maranhão, Raul Cavalcante 
Source: Cardiovascular Drugs and Therapy. Unidade: FCF
Subjects: ARTERIOSCLEROSE, NANOPARTÍCULAS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAMINELLI, Elaine N et al. Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles. Cardiovascular Drugs and Therapy, v. 30, n. 5, p. 433-443, 2016Tradução . . Disponível em: https://doi.org/10.1007/s10557-016-6675-0. Acesso em: 19 nov. 2024.APA
Daminelli, E. N., Martinelli, A. E. M., Bulgarelli, A., Freitas, F. R., & Maranhão, R. C. (2016). Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles. Cardiovascular Drugs and Therapy, 30( 5), 433-443. doi:10.1007/s10557-016-6675-0NLM
Daminelli EN, Martinelli AEM, Bulgarelli A, Freitas FR, Maranhão RC. Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles [Internet]. Cardiovascular Drugs and Therapy. 2016 ; 30( 5): 433-443.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s10557-016-6675-0Vancouver
Daminelli EN, Martinelli AEM, Bulgarelli A, Freitas FR, Maranhão RC. Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles [Internet]. Cardiovascular Drugs and Therapy. 2016 ; 30( 5): 433-443.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s10557-016-6675-0
